Stroke resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(75 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{AO}}
==Definitions==


The term 'stroke' is used to describe pathological conditions caused by brain ischemia or hemorrhage.  According to the American Heart Association/American Stroke Association (July, 2013),<ref name="Sacco-2013">{{Cite journal  | last1 = Sacco | first1 = RL. | last2 = Kasner | first2 = SE. | last3 = Broderick | first3 = JP. | last4 = Caplan | first4 = LR. | last5 = Connors | first5 = JJ. | last6 = Culebras | first6 = A. |last7 = Elkind | first7 = MS. | last8 = George | first8 = MG. | last9 = Hamdan | first9 = AD. | title = An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. | journal = Stroke | volume = 44 | issue = 7 | pages = 2064-89 | month = Jul | year = 2013 | doi = 10.1161/STR.0b013e318296aeca | PMID = 23652265 }}</ref>  the updated definitions are:
{{CMG}}; {{AE}}[[User:MoisesRomo|Moises Romo M.D.]], {{AO}}


====Ischemic Stroke====  
'''''Synonyms and Keywords:''' stroke management, stroke workup, stroke approach, approach to stroke, stroke treatment''
This is defined as an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction.
==Overview==
====CNS Infarction====
'''[[Stroke]]''' is used to describe [[pathological]] conditions caused by brain [[ischemia]] or [[hemorrhage]].  According to the American Heart Association/American Stroke Association (July, 2013),<ref name="Sacco-2013">{{Cite journal  | last1 = Sacco | first1 = RL. | last2 = Kasner | first2 = SE. | last3 = Broderick | first3 = JP. | last4 = Caplan | first4 = LR. | last5 = Connors | first5 = JJ. | last6 = Culebras | first6 = A. |last7 = Elkind | first7 = MS. | last8 = George | first8 = MG. | last9 = Hamdan | first9 = AD. | title = An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. | journal = Stroke | volume = 44 | issue = 7 |pages = 2064-89 | month = Jul | year = 2013 | doi = 10.1161/STR.0b013e318296aeca | PMID = 23652265 }}</ref>  it is defined as a [[neurological]] deficit attributed to an acute focal injury of the [[Central nervous system|central nervous system (CNS)]] by a [[vascular]] cause, including [[cerebral]] [[infarction]], [[Intracranial hemorrhage|intracerebral hemorrhage (ICH)]], and [[Subarachnoid hemorrhage|subarachnoid hemorrhage (SAH)]]. Therefore, by definition, [[trauma]] has to be ruled out before [[stroke]] can be [[Diagnosis|diagnosed]] in a patient with a focal [[neurological]] deficit.
CNS infarction is brain, spinal cord, or retinal cell death attributable to ischemia, based on:


1. Pathological, imaging, or other objective evidence of cerebral, spinal cord, or retinal focal ischemic injury in a defined vascular distribution; or
== Causes ==


2. Clinical evidence of cerebral, spinal cord, or retinal focal ischemic injury based on symptoms persisting ≥24 hours or until death, and other etiologies excluded.
=== Life Threatening Causes ===
====Hemorrhagic Stroke====
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
This is defined as rapidly developing clinical signs of neurological dysfunction attributable to a focal collection of blood within the brain parenchyma or ventricular system that is not caused by trauma.
====Time of Onset====
This is defined as when the patient was last awake and symptom-free or known to be “normal".<ref name="Jauch-2013">{{Cite journal  | last1 = Jauch | first1 = EC.| last2 = Saver | first2 = JL. | last3 = Adams | first3 = HP. | last4 = Bruno | first4 = A. | last5 = Connors | first5 = JJ. | last6 = Demaerschalk | first6 = BM. | last7 = Khatri | first7 = P. | last8 = McMullan | first8 = PW. | last9 = Qureshi | first9 = AI. | title = Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. | journal = Stroke | volume = 44 | issue = 3 | pages = 870-947 | month = Mar | year = 2013 | doi = 10.1161/STR.0b013e318284056a | PMID = 23370205 }}</ref>


==Causes==
* All [[strokes]] can potentialy lead to death or permanent disability within 24 hours if left untreated.
===Life Threatening Causes===
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
* All the causes of stroke are life-threatening.


===Common Causes===
=== Common Causes ===
====Ischemic Stroke====
*Embolic causes - [[Cardiac arrhythmia]]s, [[infective endocarditis]], [[left atrial myxoma]], [[cardiomyopathy]], atrial or ventricular thrombus


*Thrombotic causes - [[Atherosclerosis]] of large vessels, [[arteritis]]/[[vasculitis]], [[Aortic dissection|dissection]], [[Takayasu arteritis]]
* Aneurysms


*Systemic hypoperfusion (Watershed stroke) - [[Myocardial infarction]], [[cardiac arrhythmia]]s, [[pericardial effusion]], [[pulmonary embolism]]
* Atrial fibrillation
* Eclampsia
* Infective endocarditis
* Myocardial infarction
* Pulmonary embolism


====Hemorrhagic Stroke====
* Arteriovenous malformations
* [[Hypertension]]
* Atherosclerosis
* [[Haemophilia|Bleeding disorders]]
* Atrial fibrillation
* [[Drug use|Illicit drug use]] (e.g., [[amphetamines]] or [[cocaine]])
* Embolism
* Trauma
* Hypertension
* Vascular malformations 
* Subarachnoid hemorrhage
* Rupture of arterial [[aneurysms]]
* Thrombosis
* Transient ischemic attack
* Traumatic brain injury
* Warfarin


==Management==
==Diagnosis==
Shown below is an algorithm summarizing the diagnosis of [[stroke]] according to the American Academy of Neurology guidelines:
 
===Initial Evaluation===
{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | | | | | | A01 |-|-|-|-|-|-| A02 |A01=<u>Evaluation</u><br>Check vitals<br>ABCs<br>Rapid Hx - time of onset, time of arrival at the ED, medications (especially anticoagulants)<br>Rapid physical exam - neuro exam, '''NIHSS'''<br>Activate stroke team<br>'''Stat fingerstick'''<br>Labs<br>EKG, troponin, CXR<br>NPO<br>Obtain stroke protocol|A02=<u>Rule out DD</u><br>Seizure, syncope, migraine, hypoglycemia}}
{{familytree | | | | J01 | |J01=<div style="float: left; text-align: left; height: 10em; width: 20em; padding:1em;">'''Characterize the symptoms:''' <br> ❑ Sudden weakness/paralysis - face, arm or leg<br> ❑ Speech/visual difficulties<br> ❑ Altered/loss of consciousness<br> ❑ Sudden severe headache </div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | B01 |-|-|-| B02 |-|-| B03 |B01='''Non-contrast enhanced CT''' (or MRI) to r/o hemorrhage|B02='''Bleed positive'''|B03='''Hemorrhagic stroke'''}}
{{familytree | | | | H01 | | |H01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:''' <br> ❑ '''Head''' - trauma, tongue laceration <br>❑ '''Neck''' - bruits, pulses<br> ❑ '''Limbs''' - pulses <br> ❑ '''Heart''' - murmurs<br> ❑ '''Skin''' - color changes<br>❑ Neurological exam, '''NIHSS'''</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | |!|}}
{{familytree | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | C02 | | | | | | | | | | | | | | | | | |C01='''Bleed negative'''|C02=Hemorrhagic stroke algorithm}}
{{familytree | | | | G01 | | | | | |G01=<div style="float: left; text-align: left; line-height: 150% ">'''Consider alternative diagnosis:''' <br> ❑ Psychogenic <br> ❑ [[Seizures]] <br> ❑ [[Hypoglycemia]]<br> ❑ Complicated migraine<br> ❑ [[Encephalopathy|Hypertensive encephalopathy]]<br> ❑ [[Wernicke encephalopathy]]<br> ❑ [[Brain abscess]]<br> ❑ [[Brain tumor]]<br> ❑ Drug toxicity</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | D01 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |D01='''Acute ischemic stroke'''}}
{{familytree | | | | A01 |-| A02 | | | | | |A01=<div style="float: left; text-align: left; height: 10em; width: 20em; padding:1em;"> ❑ Check vitals<br> ❑ Stabilize ABC<br> ❑ Brief Hx<br>❑ Activate stroke team<br> ❑ Stat fingerstick<br> ❑ '''Labs''' - CBC, serum electrolytes, urea, creatinine, troponin, EKG, PT/PTT/INR<br> ❑ NPO<br> ❑ Obtain stroke protocol</div>|A02=<div style="float: left; text-align: left; height: 25em; width: 20em; padding:1em;">'''Other labs in selected patients:'''<br>❑ Liver function tests<br> ❑ Toxicology screen (drug abuse, stroke in the young)<br> ❑ Blood alcohol level<br>❑ Arterial blood gas (hypoxia)<br> ❑ Chest radiograph (lung disease)<br> ❑ EEG (seizures)<br> ❑ Lumbar puncture (SAH)<br> ❑ Sepsis profile - urinalysis, blood culture (if fever is present)<br> ❑ Type and cross match FFP (coagulopathy)<br> ❑ Pregnancy test (in women of child-bearing age)</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |  }}
{{familytree | | | | |!|}}
{{familytree | | | | | | | | | | | | | | | | | | | | E01 | | | | | | | | | | | | | | | | | | | | | | | | | | | |E01=Time of onset}}
{{familytree | | | | B01 | | | | | | | | |B01='''Non-Contrast Enhanced CT''' (or MRI) to r/o hemorrhage}}
{{familytree | | | | | | | | | | | | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | |,|-|^|-|.| | | | | | | | |}}
{{familytree | | | | | | | | | | | | | F01 | | | | | F02 | | | | | F03 | | | | | | | | | | | | | | | | | | | | | | |F01='''<3 hours'''|F02='''3 -4.5 hours'''|F03='''>4.5 hours'''}}
{{familytree | | C01 | | C02 | | | | | | | | | | | | | | | | | | | | | | | | |C01='''Bleed Negative'''|C02='''Bleed Positive'''}}
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | |!| | | |!| | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | G01 | | | | | G02 | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | |G01=Eligibility criteria for IV rTPA|G02=Consider rTPA}}
{{familytree | | D01 | | D02 | | | | | | | | | | | | | | | | | | | | | | | | | | | |D01=[[Ischemic stroke resident survival guide|Acute Ischemic Stroke]]|D02=[[Hemorrhagic stroke resident survival guide|Hemorrhagic Stroke]]}}
{{familytree | | | | | | | | | | | | | |!| | | | | | |!| | | | | | |!| |}}
{{familytree | | | | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|.| | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | E01 | | E02 | | |E01=[[Hemorrhagic stroke resident survival guide#Intracerebral Hemorrhage|Intracerebral Hemorrhage]]|E02=[[Subarachnoid hemorrhage resident survival guide|Subarachnoid Hemorrhage]]}}
{{familytree | | | | | H01 | | | | | | | | | | H02 | |!| | | | | | H03 | | | | | | | | | | | | | | | | | | | | | | |H01=Eligible|H02=Not eligible|H03=Blood pressure control algorithm<br><br>Treat fever with IV antipyretics}}
{{familytree/end}}<br />
{{familytree | | | | | |!| | | | | | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | }}
{{familytree | |,|-|-|-|^|-|-|-|.| | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | I01 | | | | | | I02 | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | ||I01='''BP≤180/110'''|I02='''BP≥180/110'''}}
{{familytree | |!| | | | | | | |!| | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | |  }}
{{familytree | J01 | | | | | | JO2 | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |J01=IV rTPA 0.9 mg/kg (maximum of 90 mg) with 10% given as intravenous bolus over 1 minute and the rest as IV infusion over 1 hour|JO2=Commence IV antihypertensives}}
{{familytree | |!| | | | | | | | | | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | }}
{{familytree | |!| | | | | | | | | | | | | | | | | | |!| | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | K01 |-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|'| | | | | | | | | | | | | | | | | | | | | |K01=Admit ICU for BP monitoring + bleeding complications<br>Vitals<br>Neurocheck hourly<br>Aspiration precautions}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | L01 | | | | | | | | | | | | | | | | | | | | | | | | | | | |L01='''After 24 hours post rTPA or no rTPA'''}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | M01 | | | | | | | | | | | | | | | | | | | | | | | | | | | |M01=Follow-up head CT/MRI before commencing antiplatelets}}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | |,|-|-|-|-|-|+|-|-|-|-|-|-|.| | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | N01 | | | | N02 | | | | | N03 | | | | | | | | | | | | | | | | | | | | | | |N01='''ASA''' 325 mg (if no contraindication)<br>'''Statins'''<br>'''DVT prophylaxis'''|N02=PTOT evaluation<br>Speech and swallow evaluation|N03='''Investigate the cause'''<br>MRA/CTA/carotid duplex<br>Venous doppler USS<br>Echocardiography}}
{{familytree/end}}


====Exclusion Criteria for IV Recombinant TPA Treatment==== 
== Treatment ==
'''Less than 3 hours of onset'''
The management of stroke will greatly depend on the type of stroke (if it is either hemorrhagic or ischemic).
*<font size="1"> Significant head trauma or prior stroke in previous 3 months
* Symptoms suggest subarachnoid hemorrhage
* Arterial puncture at noncompressible site in previous 7 days
* History of previous intracranial hemorrhage
* Intracranial neoplasm, arteriovenous malformation, or aneurysm
* Recent intracranial or intraspinal surgery
* Elevated blood pressure (systolic >185 mm Hg or diastolic >110 mm Hg)
* Active internal bleeding
* Acute bleeding diathesis, including but not limited to
* Platelet count <100,000/mm³
* Heparin received within 48 hours, resulting in abnormally elevated aPTT greater than the upper limit of normal
* Current use of anticoagulant with INR >1.7 or PT >15 seconds
* Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory tests (such as aPTT, INR, platelet count, and
ECT; TT; or appropriate factor Xa activity assays)
* Blood glucose concentration <50 mg/dL (2.7 mmol/L)
* CT demonstrates multilobar infarction (hypodensity >1/3 cerebral hemisphere)


Relative exclusion criteria
* To view the specific [[treatment]] of [[hemorrhagic stroke]] [[Hemorrhagic stroke management|click here]].
* Only minor or rapidly improving stroke symptoms (clearing spontaneously)
* To view the specific [[treatment]] of [[ischemic stroke]] [[Ischemic stroke medical therapy|click here]].
* Pregnancy
* Seizure at onset with postictal residual neurological impairments
* Major surgery or serious trauma within previous 14 days
* Recent gastrointestinal or urinary tract hemorrhage (within previous 21 days)
* Recent acute myocardial infarction (within previous 3 months)</font>
'''Between 3 and 4.5 hours of onset'''
* <font size="1">Aged >80 years
* Severe stroke (NIHSS>25)
* Taking an oral anticoagulant regardless of INR
* History of both diabetes and prior ischemic stroke</font>


==Management of Blood Pressure==
== Do's ==
{{familytree/start}}
 
{{familytree | | | | | | | | | A01 | | | | | | | |A01=Blood Pressure Management}}
* Perform tertiary preventive measure to decrease subsecuent episodes, such as using statins and [[Anticoagulants|anticoagulant]]<nowiki/>s, controling [[glucose]] levels and [[blood pressure]].
{{familytree | | | | | | | | | |!| | | | | | | | | |}}
{{familytree | | | | | | | | | B01 | | | | | | | | |B01='''Review Exclusion Criteria for IV rTPA Administration'''}}
{{familytree | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | |,|-|-|-|-|^|-|-|-|-|.| | | |}}
{{familytree | | | | C01 | | | | | | | | C02 | | |C01=Eligible|C02=Not eligible}}
{{familytree | |,|-|-|^|-|-|.| | | |,|-|-|^|-|-|.| |}}
{{familytree | D01 | | | | D02 | | D03 | | | | D04 | |D01=Before treatment|D02=During/After treatment|D03='''BP <220/120 mmHg'''|D04=BP >220/120 mmHg'''}}
{{familytree | |!| | | | | |!| | | |!| | | | | |!| |}}
{{familytree | E01 | | | | |!| | | E02 | | | | E03 | | |E01=<u>'''BP>185/110 mm Hg'''</u><br>[[Labetalol]] 10–20 mg IV over 1–2 minutes, may repeat 1 time; or [[nicardipine]] 5 mg/h IV infusion; titrate up by 2.5 mg/h every 5–15 minutes, maximum 15 mg/h; when desired BP reached, adjust to maintain proper BP limits; or other agents ([[hydralazine]], [[enalaprilat]], e.t.c.) may be considered when appropriate|E02='''Observe''' unless evidence of end-organ damage is present (e.g., acute [[myocardial infarction]], [[aortic dissection]], [[pulmonary edema]], [[hypertensive encephalopathy]])<br><br>Conservative management - treat fever, pain, headaches, nausea, vomiting|E03=[[Labetalol]] 10–20 mg IV over 1–2 minutes, may repeat or double every 10 minutes (maximum dose of 300 mg); or [[nicardipine]] 5 mg/h IV infusion; titrate up by 2.5 mg/h every 5–15 minutes, maximum 15 mg/h<br>'''Aim at 15% reduction during the first 24 hours afte stroke onset'''}}
{{familytree | | | | | | | |!| | | | | | | | | | | | | |}}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | | |}}
{{familytree | | | F01 | | | | | | F02 | | | |F01='''SBP>180–230 mm Hg or DBP >105–120 mm Hg'''|F02='''BP not controlled or DBP >140 mm Hg'''}}
{{familytree | | | |!| | | | | | | |!| | | |}}
{{familytree | | | G01 | | | | | | G02 | | |G01=[[Labetalol]] 10 mg IV followed by continuous IV infusion 2–8 mg/min; or [[nicardipine]] 5 mg/h IV, titrate up to desired effect by 2.5 mg/h every 5–15 minutes, maximum 15 mg/h|G02=[[Sodium nitroprusside]] 0.5 mcg/kg/min IV infusion as initial dose, then titrate to desired blood pressure}}
{{familytree/end}}


==Dos==
== Don'ts ==
* Review the criteria for the administration of IV rTPA to determine the patient's status of the patient.
* Order a limited number of investigation during the initial emergency evaluation.  Only the estimation of blood glucose should precede the administration of IV rTPA.
* Cardiac monitoring for at least the first 24 hours to screen for atrial fibrillation.
* Ensure blood pressure of ≤180/110 mmHg before initiating IV rTPA, and maintain it below 180/105 mmHg for at least the first 24 hours post-IV rTPA.
* Give ASA 325 mg within 24 to 48 hours to most patients (except if contraindicated).
* Strict blood pressure monitoring for the first 24 hours, especially if rTPA was administered - every 15 minutes for 2 hours, then every 30 mins for 6 hours, and every hour for the next 16 hours.


==Don'ts==
* Do not lower [[blood pressure]] in hypertensive patients with ischemic stroke when below
* Do not treat hypertension except the blood pressure is >220/120 mmHg, and not until CT/MRI have been performed.
* Do not initiate anticoagulation treatment within the first 24 hours.
* Do not commence oral administration of medications before speech and swallow evaluation.
* Do not delay sending the patient to CT for any reason.


<br />
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 02:26, 12 December 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D., Ayokunle Olubaniyi, M.B,B.S [2]

Synonyms and Keywords: stroke management, stroke workup, stroke approach, approach to stroke, stroke treatment

Overview

Stroke is used to describe pathological conditions caused by brain ischemia or hemorrhage. According to the American Heart Association/American Stroke Association (July, 2013),[1] it is defined as a neurological deficit attributed to an acute focal injury of the central nervous system (CNS) by a vascular cause, including cerebral infarction, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH). Therefore, by definition, trauma has to be ruled out before stroke can be diagnosed in a patient with a focal neurological deficit.

Causes

Life Threatening Causes

Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.

  • All strokes can potentialy lead to death or permanent disability within 24 hours if left untreated.

Common Causes

  • Aneurysms
  • Atrial fibrillation
  • Eclampsia
  • Infective endocarditis
  • Myocardial infarction
  • Pulmonary embolism
  • Arteriovenous malformations
  • Atherosclerosis
  • Atrial fibrillation
  • Embolism
  • Hypertension
  • Subarachnoid hemorrhage
  • Thrombosis
  • Transient ischemic attack
  • Traumatic brain injury
  • Warfarin

Diagnosis

Shown below is an algorithm summarizing the diagnosis of stroke according to the American Academy of Neurology guidelines:

Initial Evaluation

 
 
 
Characterize the symptoms:
❑ Sudden weakness/paralysis - face, arm or leg
❑ Speech/visual difficulties
❑ Altered/loss of consciousness
❑ Sudden severe headache
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:
Head - trauma, tongue laceration
Neck - bruits, pulses
Limbs - pulses
Heart - murmurs
Skin - color changes
❑ Neurological exam, NIHSS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider alternative diagnosis:
❑ Psychogenic
Seizures
Hypoglycemia
❑ Complicated migraine
Hypertensive encephalopathy
Wernicke encephalopathy
Brain abscess
Brain tumor
❑ Drug toxicity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Check vitals
❑ Stabilize ABC
❑ Brief Hx
❑ Activate stroke team
❑ Stat fingerstick
Labs - CBC, serum electrolytes, urea, creatinine, troponin, EKG, PT/PTT/INR
❑ NPO
❑ Obtain stroke protocol
 
Other labs in selected patients:
❑ Liver function tests
❑ Toxicology screen (drug abuse, stroke in the young)
❑ Blood alcohol level
❑ Arterial blood gas (hypoxia)
❑ Chest radiograph (lung disease)
❑ EEG (seizures)
❑ Lumbar puncture (SAH)
❑ Sepsis profile - urinalysis, blood culture (if fever is present)
❑ Type and cross match FFP (coagulopathy)
❑ Pregnancy test (in women of child-bearing age)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-Contrast Enhanced CT (or MRI) to r/o hemorrhage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleed Negative
 
Bleed Positive
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute Ischemic Stroke
 
Hemorrhagic Stroke
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intracerebral Hemorrhage
 
Subarachnoid Hemorrhage
 
 


Treatment

The management of stroke will greatly depend on the type of stroke (if it is either hemorrhagic or ischemic).

Do's

Don'ts

  • Do not lower blood pressure in hypertensive patients with ischemic stroke when below


References

  1. Sacco, RL.; Kasner, SE.; Broderick, JP.; Caplan, LR.; Connors, JJ.; Culebras, A.; Elkind, MS.; George, MG.; Hamdan, AD. (2013). "An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association". Stroke. 44 (7): 2064–89. doi:10.1161/STR.0b013e318296aeca. PMID 23652265. Unknown parameter |month= ignored (help)

Template:WH Template:WS